---

Dolores Schendel

Chief Executive Officer and Chief Scientific Officer, Medigene

Dolores has been a member of the German Research Foundation, German Cancer Aid and the European Research Council, and developed her interest in tumor immunology while working at the Sloan-Kettering Institute in New York. She joined Medigene as Chief Scientific Officer in 2014, when the company acquired Trianta Immunotherapy, and was appointed CEO in 2016.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018